Z-ASTD-FMK

Z-ASTD-FMK is a synthetic peptide-based caspase inhibitor widely utilized in cell biology and molecular research. As a fluoromethyl ketone (FMK) derivative of the tetrapeptide sequence Ac-Ala-Ser-Thr-Asp, it is specifically engineered to irreversibly bind and inhibit caspase enzymes, particularly those involved in apoptosis pathways. The molecule's unique structure, which includes an N-terminal benzyloxycarbonyl (Z) protective group and a C-terminal FMK moiety, confers high affinity and selectivity for caspase active sites. Its biochemical properties make it a valuable tool for dissecting protease-mediated signaling events and for exploring the mechanistic basis of programmed cell death in various experimental systems.

Apoptosis research: Z-ASTD-FMK is extensively employed in studies focused on the regulation and execution of apoptosis. By serving as an irreversible caspase inhibitor, it enables researchers to selectively block caspase-dependent proteolytic cascades, thereby elucidating the specific roles of individual caspases in cellular demise. Its use allows for the differentiation between caspase-dependent and caspase-independent cell death mechanisms, which is critical for understanding the molecular underpinnings of apoptosis in both physiological and pathological contexts.

Protease activity assays: The compound is instrumental in biochemical assays designed to measure caspase activity and to validate the specificity of caspase-targeted substrates. By providing a robust means to inhibit caspase function, Z-ASTD-FMK allows for precise quantification of residual enzymatic activity and supports the development of high-throughput screening platforms for protease modulators. Its irreversible binding characteristic ensures that inhibition is maintained throughout the duration of the assay, contributing to reproducible and interpretable results.

Cell signaling pathway analysis: In the context of cell signaling studies, Z-ASTD-FMK is used to interrogate the involvement of caspases in broader intracellular networks. By inhibiting caspase activity, researchers can assess downstream effects on signaling molecules, transcription factors, and cellular responses. This approach facilitates the mapping of signaling hierarchies and the identification of caspase-dependent checkpoints within complex biochemical pathways, providing deeper insights into cell fate decisions.

Functional genomics and proteomics: The compound supports functional genomics and proteomics investigations by enabling controlled inhibition of caspase activity during experimental manipulations. Its application in these fields helps prevent unwanted proteolytic degradation of target proteins, thereby preserving the integrity of cellular extracts for downstream analyses such as mass spectrometry, immunoprecipitation, and Western blotting. This capability is particularly valuable in studies aiming to characterize caspase substrates and to profile dynamic changes in the proteome during apoptosis or stress responses.

Drug discovery and validation: Z-ASTD-FMK is utilized in preclinical research to evaluate the efficacy and selectivity of novel caspase modulators. By serving as a reference inhibitor, it provides a benchmark for assessing the potency and mechanism of action of candidate compounds in cellular and biochemical assays. Its well-characterized inhibition profile supports the validation of screening hits and aids in the optimization of therapeutic strategies targeting apoptotic pathways, thereby accelerating the early phases of drug development.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling